VEGFA and neoplasm: It is also the first study elucidating how this variant changes VEGF-A plasma levels, by altering the binding of the NF-AT1 transcription factor to a regulatory element about 170 Kb distant from VEGFA. Similar studies in tumor types outside of the gastrointestinal tract are warranted.